121 related articles for article (PubMed ID: 38195353)
1. Differentiation of parotid pleomorphic adenoma from Warthin tumor using signal intensity ratios on fat-suppressed T2-weighted magnetic resonance imaging.
Lin W; Ye W; Ma J; Wang S; Chen P; Yang Y; Yin B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):310-319. PubMed ID: 38195353
[TBL] [Abstract][Full Text] [Related]
2. Value of T2-weighted-based radiomics model in distinguishing Warthin tumor from pleomorphic adenoma of the parotid.
Hu Z; Guo J; Feng J; Huang Y; Xu H; Zhou Q
Eur Radiol; 2023 Jun; 33(6):4453-4463. PubMed ID: 36502461
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of maximum signal intensity on T1-weighted MRI images for differentiating parotid gland tumours along with pathological correlation.
Wei PY; Shao C; Huan T; Wang HB; Ding ZX; Han ZJ
Clin Radiol; 2021 Jun; 76(6):472.e19-472.e25. PubMed ID: 33731262
[TBL] [Abstract][Full Text] [Related]
4. Imaging quality of PROPELLER diffusion-weighted MR imaging and its diagnostic performance in distinguishing pleomorphic adenomas from Warthin tumors of the parotid gland.
Liu YJ; Lee YH; Chang HC; Chung HW; Wang CW; Juan CH; Chu YH; Lee JC; Juan CJ
NMR Biomed; 2020 May; 33(5):e4282. PubMed ID: 32124504
[TBL] [Abstract][Full Text] [Related]
5. Perfusion imaging of parotid gland tumours: usefulness of arterial spin labeling for differentiating Warthin's tumours.
Kato H; Kanematsu M; Watanabe H; Kajita K; Mizuta K; Aoki M; Okuaki T
Eur Radiol; 2015 Nov; 25(11):3247-54. PubMed ID: 25921591
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Analysis and Pathological Basis of Signal Intensity on T2-Weighted MR Images in Benign and Malignant Parotid Tumors.
Wei P; Shao C; Tian M; Wu M; Wang H; Han Z; Hu H
Cancer Manag Res; 2021; 13():5423-5431. PubMed ID: 34262350
[TBL] [Abstract][Full Text] [Related]
7. Texture-based and diffusion-weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla.
Fruehwald-Pallamar J; Czerny C; Holzer-Fruehwald L; Nemec SF; Mueller-Mang C; Weber M; Mayerhoefer ME
NMR Biomed; 2013 Nov; 26(11):1372-9. PubMed ID: 23703801
[TBL] [Abstract][Full Text] [Related]
8. Clinical and demographic data improve diagnostic accuracy of dynamic contrast-enhanced and diffusion-weighted MRI in differential diagnostics of parotid gland tumors.
Mikaszewski B; Markiet K; Smugała A; Stodulski D; Szurowska E; Stankiewicz C
Oral Oncol; 2020 Dec; 111():104932. PubMed ID: 32739792
[TBL] [Abstract][Full Text] [Related]
9. T2 mapping and readout segmentation of long variable echo-train diffusion-weighted imaging for the differentiation of parotid gland tumors.
Baohong W; Jing Z; Zanxia Z; Kun F; Liang L; Eryuan G; Yong Z; Fei H; Jingliang C; Jinxia Z
Eur J Radiol; 2022 Jun; 151():110265. PubMed ID: 35472650
[TBL] [Abstract][Full Text] [Related]
10. Differentiating parotid tumors by quantitative signal intensity evaluation on MR imaging.
Matsusue E; Fujihara Y; Matsuda E; Tokuyasu Y; Nakamoto S; Nakamura K; Ogawa T
Clin Imaging; 2017; 46():37-43. PubMed ID: 28704680
[TBL] [Abstract][Full Text] [Related]
11. Radiomic model for differentiating parotid pleomorphic adenoma from parotid adenolymphoma based on MRI images.
Song LL; Chen SJ; Chen W; Shi Z; Wang XD; Song LN; Chen DS
BMC Med Imaging; 2021 Mar; 21(1):54. PubMed ID: 33743615
[TBL] [Abstract][Full Text] [Related]
12. Enhanced CT-based texture analysis and radiomics score for differentiation of pleomorphic adenoma, basal cell adenoma, and Warthin tumor of the parotid gland.
Chen F; Ge Y; Li S; Liu M; Wu J; Liu Y
Dentomaxillofac Radiol; 2023 Jan; 52(2):20220009. PubMed ID: 36367128
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of salivary gland tumors through tumor heterogeneity: a comparison between pleomorphic adenoma and Warthin tumor using CT texture analysis.
Jung YJ; Han M; Ha EJ; Choi JW
Neuroradiology; 2020 Nov; 62(11):1451-1458. PubMed ID: 32621023
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of MRI-based radiomic features for distinguishing Warthin tumor from pleomorphic adenoma: performance assessment using T2-weighted and post-contrast T1-weighted MR images.
Faggioni L; Gabelloni M; De Vietro F; Frey J; Mendola V; Cavallero D; Borgheresi R; Tumminello L; Shortrede J; Morganti R; Seccia V; Coppola F; Cioni D; Neri E
Eur J Radiol Open; 2022; 9():100429. PubMed ID: 35757232
[TBL] [Abstract][Full Text] [Related]
15. A triple-classification radiomics model for the differentiation of pleomorphic adenoma, Warthin tumour, and malignant salivary gland tumours on the basis of diffusion-weighted imaging.
Shao S; Zheng N; Mao N; Xue X; Cui J; Gao P; Wang B
Clin Radiol; 2021 Jun; 76(6):472.e11-472.e18. PubMed ID: 33752882
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of qualitative and radiomics approach to parotid gland tumors: which is the added benefit of texture analysis?
Vernuccio F; Arnone F; Cannella R; Verro B; Comelli A; Agnello F; Stefano A; Gargano R; Rodolico V; Salvaggio G; Lagalla R; Midiri M; Lo Casto A
Br J Radiol; 2021 Dec; 94(1128):20210340. PubMed ID: 34591597
[TBL] [Abstract][Full Text] [Related]
17. Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results.
Karaman CZ; Tanyeri A; Özgür R; Öztürk VS
Dentomaxillofac Radiol; 2021 May; 50(4):20200391. PubMed ID: 33237812
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative magnetic resonance imaging parameters for differentiating parotid pleomorphic adenoma from Warthin tumor.
He SN; Lu RC; Zhou JL; Wang B; Bi GL; Wu KH
Quant Imaging Med Surg; 2023 Sep; 13(9):6152-6163. PubMed ID: 37711827
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of parotid gland tumors using apparent diffusion coefficient, texture features, and their combination.
Muraoka H; Kaneda T; Kondo T; Okada S; Tokunaga S
Dentomaxillofac Radiol; 2023 Apr; 52(4):20220404. PubMed ID: 37015250
[TBL] [Abstract][Full Text] [Related]
20. Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings.
Yamamoto T; Kimura H; Hayashi K; Imamura Y; Mori M
Neuroradiology; 2018 Aug; 60(8):803-812. PubMed ID: 29968073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
